Africa

Contribution of the ECOWAS region to the African Medicines Agency

“This book is a must-read for all those with interest in medicines regulation in Africa… It provides timely expert information for consideration and possible adoption during the operationalisation of [...]

2026-02-05T14:32:47+00:00November 7th, 2025|Tags: , , |

Testing the UMBRA benefit-risk tool in a South African agency

Objectives Regulators must balance medicine benefits and risks while ensuring consistency, transparency, and efficiency in decision-making and the aim of this study was to assess UMBRA’s impact on SAHPRA [...]

2026-02-05T14:42:56+00:00July 2nd, 2025|Tags: , , , |
Go to Top